The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 337:779-781 September 11, 1997 Number 11
NextNext

Battling HIV on Many Fronts

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
After years of bad news, there is optimism in the battle against AIDS. In the United States, the number of deaths declined 19 percent in the first nine months of 1996 as compared with the same period in 1995 — from 37,900 to 30,700.1 Among the many reasons are better medical care and better treatments for human immunodeficiency virus (HIV) infection and opportunistic infections.

Two reports in this issue of the Journal provide compelling data on the benefits of a three-drug regimen consisting of a protease inhibitor and two nucleoside analogues. Hammer et al. studied 1156 patients with HIV infection, . . . [Full Text of this Article]

References


Related Letters:

Stent Placement Compared with Balloon Angioplasty for Obstructed Coronary Bypass Grafts
Bloom J. M., Savage M. P., Fischman D. L., Goldberg S.
Extract | Full Text  
N Engl J Med 1998; 338:198-199, Jan 15, 1998. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.